South Dakota Investment Council Arrowhead Pharmaceuticals, Inc. Transaction History

South Dakota Investment Council

  • $5.12 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 11, 2021
SELL
$62.15 - $90.32 $953,008 - $1.38 Million
-15,334 Closed
0 $0
Q1 2021

May 13, 2021
BUY
$61.35 - $90.47 $8,220 - $12,122
134 Added 0.88%
15,334 $1.02 Million
Q3 2019

Nov 13, 2019
BUY
$26.26 - $34.86 $399,152 - $529,872
15,200 New
15,200 $428,000

Others Institutions Holding ARWR

# of Institutions
295
Shares Held
91.1M
Call Options Held
155K
Put Options Held
426K
View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

ARWR Quotes by TradingView
  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.16B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track South Dakota Investment Council Portfolio

Follow South Dakota Investment Council and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of South Dakota Investment Council, based on Form 13F filings with the SEC.

News

Stay updated on South Dakota Investment Council with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email